Skip to main
SINT

SINT Stock Forecast & Price Target

SINT Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SINTX Technologies is an innovative leader in the developing and manufacturing of silicon nitride biomaterials. Their recent FDA clearance and partnerships with larger companies show promising results for long-term value. While facing competition and slow adoption, their unique technology and potential for use in various medical applications make them an attractive investment with an undervalued current valuation.

Bears say

SINTX Technologies is a platform-driven company with potential for value creation through product sales, partnerships, and new applications. The company's ceramic biomaterials, demonstrated in their FDA-registered manufacturing facility, has the potential to break into the orthopedic markets with differentiated properties within targeted subsegments. However, the company's competitiveness in the orthopedic and medical-device industries may hinder revenue growth in the future. The success of SINTX's product development and commercialization, as well as partnerships with companies like Evonik, will be key factors in driving sustained adoption and revenue growth.

SINT has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SINTX Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SINTX Technologies Inc (SINT) Forecast

Analysts have given SINT a Strong Buy based on their latest research and market trends.

According to 3 analysts, SINT has a Strong Buy consensus rating as of Jul 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SINTX Technologies Inc (SINT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.